<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Craneware Plc — News on 6ix</title>
<link>https://6ix.com/company/craneware-plc</link>
<description>Latest news and press releases for Craneware Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 05 May 2026 16:11:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/craneware-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d57c6dbeedb30cb6f8902f.webp</url>
<title>Craneware Plc</title>
<link>https://6ix.com/company/craneware-plc</link>
</image>
<item>
<title>Grant of Share Options to Directors</title>
<link>https://6ix.com/company/craneware-plc/news/grant-of-share-options-to-directors-2</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/grant-of-share-options-to-directors-2</guid>
<pubDate>Tue, 05 May 2026 16:11:00 GMT</pubDate>
<description>Craneware plc announced on May 5, 2026, that share options were granted to three Directors under the SAYE Option Plan (2018) at an exercise price of £11.594 per share. CEO Keith Neilson and CFO Craig Preston each received options for 1,569 shares, representing 0.005% of the issued share capital, while Chief People Officer Isabel Urquhart received options for 784 shares, representing 0.002%. These options are exercisable after a three-year savings term and are part of the company's approved emplo</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/craneware-plc/news/transaction-in-own-shares-690</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/transaction-in-own-shares-690</guid>
<pubDate>Fri, 17 Apr 2026 06:00:00 GMT</pubDate>
<description>Craneware plc has announced the purchase of 132,383 of its ordinary shares on the London Stock Exchange between April 10th and April 16th, 2026. The shares were acquired at prices ranging from 1,374.00 GBp to 1,486.00 GBp, with a volume-weighted average price of 1,428.07 GBp. Following these transactions, Craneware will hold 712,673 shares in treasury, leaving 34,829,496 ordinary shares in issue, which represents the total voting rights.
Disclaimer*</description>
</item>
<item>
<title>Block Admission</title>
<link>https://6ix.com/company/craneware-plc/news/block-admission-8</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/block-admission-8</guid>
<pubDate>Wed, 15 Apr 2026 06:00:00 GMT</pubDate>
<description>Craneware plc has announced its six-monthly Schedule 6 block admission update, confirming that no new ordinary shares were issued or allotted under its various employee share plans between October 16, 2025, and April 15, 2026. The company's remaining unallotted securities under these plans total 776,671 ordinary shares, with the largest balance of 342,301 shares held under the Approved Share Option Plan 2007. The original admission for 24,929,950 ordinary shares occurred on September 13, 2007.
</description>
</item>
<item>
<title>Grant of Share Option to PDMR</title>
<link>https://6ix.com/company/craneware-plc/news/grant-of-share-option-to-pdmr</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/grant-of-share-option-to-pdmr</guid>
<pubDate>Mon, 13 Apr 2026 09:37:00 GMT</pubDate>
<description>Craneware plc announced on April 13, 2026, that its Chief Legal Officer, a person discharging managerial responsibilities, was granted a share option on April 10, 2026, to acquire 1,004 ordinary shares at an exercise price of £11.594 per share under the company's Employee Stock Purchase Plan. This option, granted on the same terms as other US employees, will ordinarily become exercisable after a two-year savings term.
Disclaimer*</description>
</item>
<item>
<title>Dividend Currency Election</title>
<link>https://6ix.com/company/craneware-plc/news/dividend-currency-election-4</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/dividend-currency-election-4</guid>
<pubDate>Fri, 20 Mar 2026 11:26:00 GMT</pubDate>
<description>Craneware plc has provided an update regarding its interim dividend, announcing that shareholders who elected to receive their payment in US dollars will receive it at an exchange rate of $1.33. This information is supplementary to the dividend announcement made on March 2, 2026.
Disclaimer*</description>
</item>
<item>
<title>Share buyback programme and Total Voting Rights</title>
<link>https://6ix.com/company/craneware-plc/news/share-buyback-programme-and-total-voting-rights</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/share-buyback-programme-and-total-voting-rights</guid>
<pubDate>Mon, 16 Mar 2026 07:00:00 GMT</pubDate>
<description>Craneware plc has announced the commencement of a share buyback programme to purchase up to $25 million of its ordinary shares, believing the current market price undervalues the company's strategic position and market opportunity. Shares acquired will be held in treasury to cover employee share incentives and then cancelled, aiming to enhance shareholder returns, increase earnings per share, and offset dilution. The company's total voting rights are now 35,514,105 ordinary shares.
</description>
</item>
<item>
<title>The Craneware Group Reinforces Financial Performance, Leadership, and AI Innovation at HIMSS26</title>
<link>https://6ix.com/company/craneware-plc/news/the-craneware-group-reinforces-financial-performance-leadership-and-ai-innovation-at-himss26</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/the-craneware-group-reinforces-financial-performance-leadership-and-ai-innovation-at-himss26</guid>
<pubDate>Thu, 05 Mar 2026 14:05:00 GMT</pubDate>
<description>The Craneware Group will showcase sustained enterprise financial performance leadership at HIMSS Global Health Conference & Exhibition, highlighted by its 15th Best in KLAS® recognition for Trisus Chargemaster and expanded AI capabilities embedded across the Trisus® platform.</description>
</item>
<item>
<title>Director's Acquisition of Shares</title>
<link>https://6ix.com/company/craneware-plc/news/directors-acquisition-of-shares</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/directors-acquisition-of-shares</guid>
<pubDate>Wed, 04 Mar 2026 07:00:00 GMT</pubDate>
<description>Craneware plc announced that CEO Keith Neilson exercised options to acquire 28,628 ordinary shares at 750 pence each, costing him over £326,000 to retain the full award. This transaction increases his total shareholding to 3,214,471 ordinary shares, representing 9.05% of the company's issued share capital.
Disclaimer*</description>
</item>
<item>
<title>FY26 Interim Results</title>
<link>https://6ix.com/company/craneware-plc/news/fy26-interim-results-5</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/fy26-interim-results-5</guid>
<pubDate>Mon, 02 Mar 2026 07:00:00 GMT</pubDate>
<description>Craneware plc reported a strong first half of fiscal year 2026, with revenue increasing by 6% to $105.7 million and adjusted EBITDA growing by 10% to $33.4 million, demonstrating double-digit adjusted EBITDA and EPS growth. The company saw a significant increase in sales to new customers, now representing 12% of total sales, and maintained a healthy Net Revenue Retention rate of 103%. Investments in AI through a Microsoft partnership are driving accelerated innovation, with new Trisus functional</description>
</item>
<item>
<title>Notification of Major Holdings</title>
<link>https://6ix.com/company/craneware-plc/news/notification-of-major-holdings-215</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/notification-of-major-holdings-215</guid>
<pubDate>Wed, 18 Feb 2026 15:49:00 GMT</pubDate>
<description>Aegon Ltd. has notified Craneware plc of a change in its major holding, with its total voting rights now standing at 4.962% representing 1,761,971 shares, a decrease from its previous holding of 5.168%. This acquisition or disposal of voting rights occurred on February 16, 2026, and was reported to the issuer on February 18, 2026. The notification indicates no holdings through financial instruments.
Disclaimer*</description>
</item>
<item>
<title>The Craneware Group Named 2026 Best in KLAS® for Trisus® Chargemaster</title>
<link>https://6ix.com/company/craneware-plc/news/the-craneware-group-named-2026-best-in-klasr-for-trisusr-chargemaster</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/the-craneware-group-named-2026-best-in-klasr-for-trisusr-chargemaster</guid>
<pubDate>Wed, 04 Feb 2026 14:00:00 GMT</pubDate>
<description>The Craneware Group, a leading innovator in healthcare technology, today announced that its Trisus® Chargemaster solution has been named 2026 Best in KLAS® for Revenue Cycle – Chargemaster Management. This marks the 15th time The Craneware Group's chargemaster solution has received this top honor, reflecting sustained customer trust, measurable outcomes, and the company's role as a long-term partner to healthcare organizations navigating increasing financial and operational complexity.</description>
</item>
<item>
<title>H1 FY26 Trading Update and Notice of Results</title>
<link>https://6ix.com/company/craneware-plc/news/h1-fy26-trading-update-and-notice-of-results</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/h1-fy26-trading-update-and-notice-of-results</guid>
<pubDate>Tue, 20 Jan 2026 07:00:00 GMT</pubDate>
<description>Craneware plc reported a strong first half for FY26, with revenue increasing 6% to approximately $106 million and Adjusted EBITDA growing to $33.4 million. Annual Recurring Revenue (ARR) rose by 4% to $184.3 million, supported by sales and net revenue retention above 100%. The company reduced its total bank debt to $23.4 million while maintaining healthy cash reserves of $71.2 million. Despite a temporary halt to a US 340B program pilot impacting some revenue, Craneware remains on track to deliv</description>
</item>
<item>
<title>Result of AGM</title>
<link>https://6ix.com/company/craneware-plc/news/result-of-agm-1133</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/result-of-agm-1133</guid>
<pubDate>Fri, 21 Nov 2025 13:51:00 GMT</pubDate>
<description>Craneware plc announced that all resolutions were passed at its Annual General Meeting, with significant shareholder support for each item, including resolutions related to the approval of financial statements and the re-appointment of directors. For example, Resolution 01 received 24,493,708 votes in favour out of a total of 24,507,054 votes cast, indicating strong endorsement from shareholders.
Disclaimer*</description>
</item>
<item>
<title>Vesting of LTIP Awards and Total Voting Rights</title>
<link>https://6ix.com/company/craneware-plc/news/vesting-of-ltip-awards-and-total-voting-rights</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/vesting-of-ltip-awards-and-total-voting-rights</guid>
<pubDate>Thu, 20 Nov 2025 07:00:00 GMT</pubDate>
<description>Craneware plc announced that on November 18, 2025, conditional awards from its Long Term Incentive Plan vested for three Directors and the Chief Legal Officer, with net shares received after tax liabilities totaling 10,241 for Keith Neilson, 7,612 for Craig Preston, 5,232 for Isabel Urquhart, and 7,755 for Eric Carter, all subject to a two-year holding period. Following these transactions, the company's total voting rights are 35,508,820 ordinary shares, reflecting the issuance of 76,953 shares </description>
</item>
<item>
<title>Reduction of Capital effective</title>
<link>https://6ix.com/company/craneware-plc/news/reduction-of-capital-effective-5</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/reduction-of-capital-effective-5</guid>
<pubDate>Thu, 13 Nov 2025 10:51:00 GMT</pubDate>
<description>Craneware plc announced that its Reduction of Capital, approved by shareholders and confirmed by the Court of Session, became effective on November 7, 2025, after being registered by the Registrar of Companies. This action creates additional distributable reserves of $284,185,184.18, though it does not involve any distribution or repayment of capital and does not reduce the company's underlying net assets.
Disclaimer*</description>
</item>
<item>
<title>Reduction of Capital confirmed</title>
<link>https://6ix.com/company/craneware-plc/news/reduction-of-capital-confirmed</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/reduction-of-capital-confirmed</guid>
<pubDate>Thu, 06 Nov 2025 15:41:00 GMT</pubDate>
<description>Craneware plc announced on 6 November 2025 that the Court of Session confirmed its Reduction of Capital, previously approved by shareholders on 20 August 2025. This action, comprising a Share Premium Reduction and Merger Reserve Reduction, will create additional distributable reserves totaling US$ 284,185,184.18. The company clarified that this process does not involve any distribution or repayment of capital, share premium, or merger reserve, nor does it reduce the underlying net assets. The Re</description>
</item>
<item>
<title>The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot</title>
<link>https://6ix.com/company/craneware-plc/news/the-craneware-group-hosts-340b-rebate-forum-confirms-no-new-vendor-needed-for-pilot</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/the-craneware-group-hosts-340b-rebate-forum-confirms-no-new-vendor-needed-for-pilot</guid>
<pubDate>Fri, 31 Oct 2025 18:00:00 GMT</pubDate>
<description>The Craneware Group convened leaders from 25 major U.S. health systems, alongside representatives from Beacon/ESP (Berkeley Research Group) and Apexus, the HRSA 340B Prime Vendor, at its U.S. headquarters this week to align on readiness for the now-approved 340B Rebate Model Pilot Program.</description>
</item>
<item>
<title>Annual Report, Notice of AGM, Directorate Change</title>
<link>https://6ix.com/company/craneware-plc/news/annual-report-notice-of-agm-directorate-change</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/annual-report-notice-of-agm-directorate-change</guid>
<pubDate>Wed, 22 Oct 2025 16:17:00 GMT</pubDate>
<description>Craneware plc announced the posting of its Annual Report and Accounts for the year ended June 30, 2025, along with the Notice of the Annual General Meeting (AGM). The AGM is scheduled for November 21, 2025, at 10 am UK time. David Kemp, Senior Non-Executive Director and Chair of the Audit Committee, will retire from the Board on November 21, 2025, after nearly six years of service, as he will not stand for re-election at the upcoming AGM. The Board will provide an update on the recruitment of a </description>
</item>
<item>
<title>Block listing Interim Review</title>
<link>https://6ix.com/company/craneware-plc/news/block-listing-interim-review-320</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/block-listing-interim-review-320</guid>
<pubDate>Wed, 15 Oct 2025 06:00:00 GMT</pubDate>
<description>Craneware plc reports on their block admission period from April 16, 2025, to October 15, 2025, for employee share plans. The balance of unallotted securities from the previous return includes 342,301 ordinary shares under the Approved Share Option Plan 2007, 50,000 ordinary shares under the Schedule 4 Company Share Option Plan 2016, and 200,000 ordinary shares under the Unapproved Company Share Option Plan 2016. Additionally, there are 100,000 ordinary shares each for the Long Term Incentive Pl</description>
</item>
<item>
<title>Grant of Long Term Incentive Plan Awards</title>
<link>https://6ix.com/company/craneware-plc/news/grant-of-long-term-incentive-plan-awards-2</link>
<guid isPermaLink="true">https://6ix.com/company/craneware-plc/news/grant-of-long-term-incentive-plan-awards-2</guid>
<pubDate>Wed, 17 Sep 2025 06:00:00 GMT</pubDate>
<description>On September 16, 2025, Craneware plc granted conditional share awards under its Long Term Incentive Plan (2022) to three directors and its Chief Legal Officer. Keith Neilson, Director & CEO, received an award of 23,199 shares, representing 0.066% of the company's issued share capital. Craig Preston, Director & CFO, was granted 36,864 shares, or 0.104%. Isabel Urquhart, Director & CPO, received 23,898 shares, amounting to 0.067%. Eric Carter, the Chief Legal Officer, was granted 7,828 shares, rep</description>
</item>
</channel>
</rss>